Skip to main content

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

A Study to Evaluate CC-92480 in Combination With Carfilzomib and Dexamethasone (480Kd) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about A Study to Evaluate CC-92480 in Combination With Carfilzomib and Dexamethasone (480Kd) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma

Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)

Efficacy and Tolerability of a Fractional Ablative Erbium Laser for Axillary Scarring for Hidradenitis Suppurativa Patients

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Efficacy and Tolerability of a Fractional Ablative Erbium Laser for Axillary Scarring for Hidradenitis Suppurativa Patients

1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about 1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia

Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS

A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache

A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 29
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Page 35
  • Page 36
  • Page 37
  • …
  • Next page Next
  • Last page Last
Subscribe to